Mark R. Marshall

6.4k total citations
147 papers, 4.0k citations indexed

About

Mark R. Marshall is a scholar working on Nephrology, Emergency Medical Services and Economics and Econometrics. According to data from OpenAlex, Mark R. Marshall has authored 147 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Nephrology, 42 papers in Emergency Medical Services and 25 papers in Economics and Econometrics. Recurrent topics in Mark R. Marshall's work include Dialysis and Renal Disease Management (98 papers), Central Venous Catheters and Hemodialysis (41 papers) and Acute Kidney Injury Research (29 papers). Mark R. Marshall is often cited by papers focused on Dialysis and Renal Disease Management (98 papers), Central Venous Catheters and Hemodialysis (41 papers) and Acute Kidney Injury Research (29 papers). Mark R. Marshall collaborates with scholars based in New Zealand, United States and Australia. Mark R. Marshall's co-authors include Stephen P. McDonald, Kevan R. Polkinghorne, Rachael Walker, Thomas A. Golper, David W. Johnson, Peter G. Kerr, Rachael L. Morton, Kirsten Howard, Mary Jo Shaver and Dinesh K. Chatoth and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Epidemiology.

In The Last Decade

Mark R. Marshall

146 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Marshall New Zealand 32 3.1k 980 775 470 440 147 4.0k
Jeffrey Perl Canada 32 2.4k 0.8× 956 1.0× 565 0.7× 525 1.1× 668 1.5× 198 3.8k
Francesca Tentori United States 39 4.2k 1.4× 682 0.7× 904 1.2× 449 1.0× 957 2.2× 96 5.5k
Roger Greenwood United Kingdom 30 3.0k 1.0× 1.3k 1.3× 948 1.2× 450 1.0× 823 1.9× 74 4.2k
Daniele Marcelli Germany 36 3.6k 1.2× 1.1k 1.1× 1.2k 1.6× 236 0.5× 750 1.7× 155 5.0k
Ikechi G. Okpechi South Africa 28 2.5k 0.8× 454 0.5× 449 0.6× 382 0.8× 426 1.0× 142 4.4k
Elisabeth W. Boeschoten Netherlands 43 5.1k 1.6× 1.5k 1.5× 1.2k 1.6× 921 2.0× 727 1.7× 91 6.2k
Brian Bieber United States 31 2.1k 0.7× 442 0.5× 474 0.6× 282 0.6× 375 0.9× 125 3.4k
Gihad Nesrallah Canada 27 1.7k 0.6× 882 0.9× 555 0.7× 315 0.7× 354 0.8× 89 2.5k
Hugh C. Rayner United Kingdom 37 3.6k 1.2× 1.5k 1.6× 971 1.3× 586 1.2× 1.1k 2.6× 80 5.7k
Paul Komenda Canada 36 2.4k 0.8× 460 0.5× 460 0.6× 444 0.9× 617 1.4× 173 4.3k

Countries citing papers authored by Mark R. Marshall

Since Specialization
Citations

This map shows the geographic impact of Mark R. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Marshall more than expected).

Fields of papers citing papers by Mark R. Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Marshall. The network helps show where Mark R. Marshall may publish in the future.

Co-authorship network of co-authors of Mark R. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Marshall. A scholar is included among the top collaborators of Mark R. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Marshall. Mark R. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katial, Rohit, Yanjun Liu, Xiaoyu Lu, et al.. (2025). Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials. Gene Therapy. 32(3). 223–236. 1 indexed citations
2.
3.
Marshall, Mark R., et al.. (2024). Structural Equation Modelling to Identify Psychometric Determinants of Medication Adherence in a Survey of Kidney Dialysis Patients. Patient Preference and Adherence. Volume 18. 855–878. 1 indexed citations
4.
Marshall, Mark R., et al.. (2024). Low dialysate sodium levels for chronic haemodialysis. Cochrane Database of Systematic Reviews. 2024(11). CD011204–CD011204. 1 indexed citations
5.
Kawanishi, Hideki, Mark R. Marshall, Junhui Zhao, et al.. (2021). Mortality, hospitalization and transfer to haemodialysis and hybrid therapy, in Japanese peritoneal dialysis patients. Peritoneal Dialysis International. 42(3). 305–313. 13 indexed citations
6.
McLean, Rachael, et al.. (2018). Dietary Sodium and Other Nutrient Intakes among Patients Undergoing Hemodialysis in New Zealand. Nutrients. 10(4). 502–502. 14 indexed citations
7.
Brint, Andrew, et al.. (2018). Using grouped smart meter data in phase identification. Computers & Operations Research. 96. 213–222. 10 indexed citations
8.
Lovell, Sarah, Robert Walker, John Schollum, et al.. (2017). To dialyse or delay: a qualitative study of older New Zealanders’ perceptions and experiences of decision-making, with stage 5 chronic kidney disease. BMJ Open. 7(3). e014781–e014781. 29 indexed citations
9.
10.
Derrett, Sarah, Ari Samaranayaka, John Schollum, et al.. (2017). Predictors of Health Deterioration Among Older Adults After 12 Months of Dialysis Therapy: A Longitudinal Cohort Study From New Zealand. American Journal of Kidney Diseases. 70(6). 798–806. 14 indexed citations
11.
Marshall, Mark R. & Christopher T. Chan. (2016). The Evolution of Home HD - Meeting Modern Patient Needs. Contributions to nephrology. 189. 36–45. 9 indexed citations
12.
Walker, Rachael, Rachael L. Morton, Allison Tong, et al.. (2015). Patient and caregiver preferences for home dialysis—the home first study: a protocol for qualitative interviews and discrete choice experiments. BMJ Open. 5(4). e007405–e007405. 18 indexed citations
13.
Nakayama, Masaaki, Mari Ishida, Masahiko Ogihara, et al.. (2015). Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: A multi‐centre survey of Japanese patients. Nephrology. 20(8). 523–530. 27 indexed citations
14.
Dunlop, Joanna, Alain C. Vandal, Janak de Zoysa, et al.. (2014). Rationale and design of the myocardial microinjury and cardiac remodeling extension study in the sodium lowering in dialysate trial (Mac-SoLID study). BMC Nephrology. 15(1). 120–120. 4 indexed citations
15.
Marshall, Mark R., Rachael Walker, Kevan R. Polkinghorne, & Kelvin L. Lynn. (2014). Survival on Home Dialysis in New Zealand. PLoS ONE. 9(5). e96847–e96847. 40 indexed citations
16.
Wolley, Martin, et al.. (2014). Cephazolin and Gentamicin Are Stable in Lactate-Buffered Fresenius Peritoneal Dialysate for Seven Days at Room Temperature. Peritoneal Dialysis International. 34(2). 227–232. 3 indexed citations
17.
Marshall, Mark R., et al.. (2012). Independent Community House Hemodialysis as a Novel Dialysis Setting: An Observational Cohort Study. American Journal of Kidney Diseases. 61(4). 598–607. 26 indexed citations
18.
Nesrallah, Gihad, Rita S. Suri, Louise Moist, et al.. (2008). The International Quotidian Dialysis Registry: Annual report 2008. Hemodialysis International. 12(3). 281–289. 5 indexed citations
19.
Marshall, Mark R., et al.. (2007). Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain. Nephrology Dialysis Transplantation. 22(9). 2630–2639. 73 indexed citations
20.
Marshall, Mark R., et al.. (2006). Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney International. 69(7). 1229–1236. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Perl Breakdown of academic impact, for papers by Francesca Tentori Breakdown of academic impact, for papers by Roger Greenwood Breakdown of academic impact, for papers by Daniele Marcelli Breakdown of academic impact, for papers by Ikechi G. Okpechi Breakdown of academic impact, for papers by Elisabeth W. Boeschoten Breakdown of academic impact, for papers by Brian Bieber Breakdown of academic impact, for papers by Gihad Nesrallah Breakdown of academic impact, for papers by Hugh C. Rayner Breakdown of academic impact, for papers by Paul Komenda
Rankless by CCL
2026